With the move of molecular tests from diagnostic labs to on-site testing becoming more
common, there is a sudden rise in demand for nucleic acid-based diagnostic tools that are …

Abstract In Vitro Diagnosis (IVD) technology is able to accurately detect pathogens or
biomarkers at an initial stage of disease, which works as an important toolbox for disease …

Infectious diseases (such as sepsis, influenza, and malaria), caused by various pathogenic
bacteria and viruses, are widespread across the world. Early and rapid detection of disease …

The outbreak of the emerging SARS-CoV-2 virus has highlighted the challenges of detecting
viral infections, especially in resource-limited settings. The SARS-CoV-2 virus transmission …

For infectious diseases, rapid and accurate identification of the pathogen is critical for
effective management and treatment, but diagnosis remains challenging, particularly in …

The current pandemic of the 2019 novel coronavirus (COVID-19) caused by SARS-CoV-2
(severe acute respiratory syndrome coronavirus-2) has raised significant public health …

In the fight against the worldwide pandemic coronavirus disease 2019 (COVID-19), simple,
rapid, and sensitive tools for nucleic acid detection are in urgent need. PCR has been a …

The CRISPR (Clustered Regularly Spaced Short Palindromic Repeats) system was first
discovered in prokaryotes as a unique immune mechanism to clear foreign nucleic acids. It …

Accurate and rapid detection of pathogens is essential for food safety, epidemic prevention,
disease diagnosis and environmental monitoring. So far, many CRISPR/Cas systems have …

Pathogenic biosafety is a worldwide concern. Tools for analyzing pathogenic biosafety, that
are precise, rapid and field-deployable, are highly demanded. Recently developed …